Rating
Buy
Price target
$255
Previous
$215
Implied upside
+23%

BofA Securities analyst Mariana Perez Mora raised the price target on Palantir to $255 (from $215) while maintaining a Buy rating.

On the notion of real vs. fake “AI” – we continue to expect growth would accelerate as more businesses and government realize the choices in front of them.

PLTR’s “red pill” offers boot camps, an expensive software kit, deep FDE expertise, an Ontology implementation path that prioritizes ROI, and the ability to scale with AI FDEs.

We still view this go-to-market and approach as a winning differentiated formula while others continue to push a “blue pill” option: generic, one-size-fits-most, Chat-GPT wrappers.

We reiterate our Buy rating and raise our PO to $255 (from $215) which reflects our confidence in PTLR’s enduring position and better than expected growth (see details on page 4) on a 15x EV/EBITDA on 2035E (unchanged).”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Share

Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.